SynthesisTargeted oncology2021

Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer: A Systematic Review.

Ziran Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.